Key result
GLP-1 RA prescriptions in Veterans with CKD exhibit racial, ethnic, and facility-level disparities.
Key points are not available for this paper at this time.
Should not yet change prescribing practices; leaves open whether disparities affect outcomes in veterans with CKD.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Gregg et al. (2023) studied this question. GLP-1 receptor agonist prescriptions among US Veterans with chronic kidney disease exhibit racial and ethnic disparities as well as facility-level variation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: